sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Systemic Aspergillosis And Systemic Candidasis Market Scope And Analysis

  • Report Code : TIPRE00020066
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 127
Buy Now

North America Systemic Aspergillosis and Systemic Candidasis Market Analysis and Scope (2020 to 2027)

Buy Now

North America Systemic Aspergillosis and Systemic Candidasis Market Report North America Systemic Aspergillosis and Systemic Candidasis Market Size and Share North America Systemic Aspergillosis and Systemic Candidasis Market Scope and Analysis

North America Systemic Aspergillosis and Systemic Candidasis Market Report Scope

Report Attribute Details
Market size in 2019 US$ 2,423.82 Million
Market Size by 2027 US$ 3,352.62 Million
Global CAGR (2020 - 2027) 4.2%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Type
  • Voriconazole
  • Liposomal
  • Amphotericin B
  • Systemic Oral Azoles
  • Topical
  • Antifungal Agents
By Application
  • Chronic
  • Pulmonary Aspergillosis
  • Allergic
  • Bronchopulmonary Aspergillosis
  • Gastrointestinal Candidiasis
  • Genitourinary Tract Candidiasis
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Novartis AG
  • Sanofi
  • Pfizer Inc
  • Merck Co Inc
  • Bayer AG
  • Astellas Pharma Inc
  • GlaxoSmithKline plc
  • Abbott
  • Cipla Inc